Current Search Criteria: Intervention: Daratumumab, dexamethasone, ixazomib, pomalidomide
Found 8 matching trials
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) PHASE3 This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Show More Location
Local Institution - 109
Learn More & Join Trial
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis PHASE1 The purpose of this study is assess safety, safest dose, and effectiveness ...
Show More Status
Active Not Recruiting
Location
Boston Medical Center
Learn More & Join Trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients PHASE1 This study will independently assess the efficacy and safety of 11 combinat...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma PHASE2 The purpose of this study is to determine the overall response rate of pati...
Show More Location
UCSD Moores Cancer Center
Learn More & Join Trial
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies PHASE1 A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Show More Location
Emory Winship Cancer Institute
Learn More & Join Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG) PHASE1 The MyDRUG study is a type of Precision Medicine trial to treat patients wi...
Show More Location
Mayo Clinic - Arizona
Treatments Being Tested
Abemaciclib, dexamethasone, ixazomib, pomalidomide Enasidenib, dexamethasone, ixazomib, pomalidomide Cobimetinib, dexamethasone, ixazomib, pomalidomide Erdafitinib, dexamethasone, ixazomib, pomalidomide Venetoclax, dexamethasone, ixazomib, pomalidomide Daratumumab, dexamethasone, ixazomib, pomalidomide Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide Selinexor, dexamethasone, ixazomib, pomalidomide Learn More & Join Trial
Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib PHASE2 Adult patients with a confirmed diagnosis of symptomatic and relapsed and/o...
Show More Status
Active Not Recruiting
Location
Emek Medical Center
Learn More & Join Trial
Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy PHASE3 Allogeneic stem cell (allo SCT) transplantation for multiple myeloma is a p...
Show More Location
University Hospital of Freiburg
Learn More & Join Trial